期刊文献+

微小RNA-203对Ⅳ型胶原蛋白α4链基因的靶向调控及其在口腔黏膜下纤维化中的作用 被引量:4

Target regulation of micro-RNA-203 to the expression of collagen type Ⅳ alpha 4 and its role in oral submucous fibrosis
原文传递
导出
摘要 目的 构建微小RNA-203(microRNA-203,miR-203)表达质粒和Ⅳ型胶原蛋白α4链(collagen typeⅣalpha 4,COL4A4) 3'UTR荧光素酶报告基因,探究miR-203对COL4A4的靶向调控作用及其在口腔黏膜下纤维化(oral submucous fibrosis,OSF)中的作用.方法 通过生物信息学软件对miR-203可能调控的靶基因进行预测,结合其生物学功能,筛选出miR-203可能的靶基因COL4A4.收集2016年1至4月在中南大学湘雅口腔医院黏膜科就诊、具有典型病理特征、未经治疗、不伴其他口腔疾病的9例OSF患者颊黏膜组织(OSF组)及其配对的正常组织(对照组),应用蛋白质印迹法检测两组标本中COL4A4的表达,实时定量聚合酶链反应法检测miR-203的相对表达量.通过生物信息学软件(http://www.targetscan.org/)寻找COL4A4基因3UTR与miR-203之间的作用位点.将COL4A4基因3 UTR包括miR-203结合位点、上下游部分侧翼序列以及酶切位点在内共60 bp片段分别克隆入哺乳动物细胞miRNA表达报告载体(pMIR-REPORT Luciferase)荧光素酶报告基因载体,将其分别与β-半乳糖苷酶表达质粒及miR-203表达载体共转染293T细胞,24 h后检测报告基因活性.结果 COL4A4的相对表达水平OSF组(2.46±2.26)显著高于对照组(0.70±0.49)(P<0.05);miR-203的相对表达水平(2-△△CT) OSF组(2.57±2.09)显著低于对照组(154.07±191.11)(P<0.01).生物信息预测显示,COL4A4基因3'UTR与miR-203之间有一物种间保守作用位点(位点1),3个非保守作用位点(位点2,3,4);miR-203能明显抑制位点1介导的报告基因活性,能部分抑制位点2与位点4介导的报告基因活性,而对位点3介导的报告基因活性无显著影响.结论 在OSF组织中,miR-203与COL4A4的蛋白表达呈负相关,miR-203靶向结合COL4A4基因3'UTR,抑制COL4A4蛋白表达. Objective To explore the effect of microRNA-203(miR-203) on the expression of collagen type Ⅳ alpha 4(COL4A4) and its role in oral submucous fibrosis(OSF).Methods It has been revealed that COL4A4 is the putative target of miR-203 by retrieving a variety of bioinformatics software tools.The expression of COL4A4 protein in the indicated tissues was examined by Western blotting analysis and the potential binding sites of miR-203 and COL4A4-3'UTR was analyzed by using bioinformatics.This study integrated a fragment of COL4A4 3'UTR containing the target sequence into the pMIR-REPORT luciferase vector.Then,the COL4A4 3'UTR-luciferase and miR-203 were contransfected into 293T cells.Beta-gal was used as a control to monitor transfection efficiency.Cells were harvested and luciferase activity was measured after 24 h of transfection.Results The relative expression mean valves of COL4A4 were 2.46±2.26 in OSF and 0.70±0.49 in normal control.The expression of COL4A4 in OSF was higher than normal control(P〈0.05) and the difference between groups was statistically significant.The relative expression mean valves of miR-203 were 2.57±2.09 in OSF and 154.07±191.11 in normal control.The expression of miR-203 in OSF was lower than in normal control(P〈0.01) and the difference between groups was statistically significant.Bioinformatics analysis revealed that the COL4A4 3'UTR had a conserved site (site 1) and 3 non-conserved sites(site 2,site 3,site4) complementary to the miR-203.MiR-203 could significantly inhibit site 1-luciferase reporter activity,partially inhibited site 3-and site 4-1uciferase reporter activities,while no significant effect on site 3-luciferase reporter activity.Conclusions MiR-203 was negatively correlated with the expression of COL4A4 protein in OSF.Moreover,miR-203 repressed the expression of COL4A4 by targeting 3'UTR site of COL4A4 mRNA.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2016年第9期526-531,共6页 Chinese Journal of Stomatology
关键词 口腔黏膜下纤维化 基因 报告 Ⅳ型胶原α4链 COLLAGEN type ALPHA 4 微小RNA Oral submucous fibrosis MicroRNA Genes,reporter
  • 相关文献

参考文献25

  • 1Pindborg JJ, Murti PR, Bhonsle RB, et al. Oral submucousfibrosis as a precancerous condition[J]. Scand J Dent Res,1984,92(3); 224-229. 被引量:1
  • 2Reichart PA. Oral precancerous conditions ; an overview[J].Mund Kiefer Gesichtschir, 2003, 7(4); 201-207. DOI; 10.1007/sl0006-003-0483-y. 被引量:1
  • 3Cox SC, Walker DM. Oral submucous fibrosis. A review[J].Aust Dent J, 1996, 41(5); 294-299. 被引量:1
  • 4Li Q, Frank M, Thisse Cl, et ah ZebraJlsh; a model system tostudy heritable skin diseases[J]. J Invest Dermatol, 2011, 131(3); 565-571. DOI; 10.1038/jid.2010.388. 被引量:1
  • 5Feitosa NM, Richardson R, Bloch W,et al. Basementmembrane diseases in zebrafish[J]. Methods Cell Biol, 2011,105; 191-222. DOI; 10.1016/B978-0-12-381320-6.00008-4. 被引量:1
  • 6Abreu-Velez AM, Howard MS. Collagen IV in normal skinand in pathological processes[J]. N Am J Med Sci, 2012, 4(1);1-8. 被引量:1
  • 7Kruegel J, Rubel D, Gross 0. Alport syndrome; insights frombasic and clinical research[J]. Nat Rev Nephrol, 2013, 9(3);170-178. DOI; 10.1038/nmeph.2012.259. 被引量:1
  • 8Savva I,Pierides A, Deltas C. RAAS inhibition and the courseof Alport syndrome[J]. Pharmacol Res, 2016, 107; 205-210.DOI; 10.1016/j.phrs.2016.03.017. 被引量:1
  • 9Jefferson JA, Lemmink HH, Hughes AE, et al. Autosomaldominant Alport syndrome linked to the type IV collage alpha3 and alpha 4 genes (COL4A3 and COL4A4) [J]. Nephrol DialTransplant, 1997, 12(8); 1595-1599. 被引量:1
  • 10Lu W, Phillips CL, Killen PD, et al. Insertional mutation ofthe collagen genes Col4a3 and Col4a4 in a mouse model ofAlport syndrome[J]. Genomics, 1999, 61(2); 113-124. DOI;10.1006/geno.l999.5943. 被引量:1

同被引文献41

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部